Prevail and Lonza Deepen Partnership with New Collaboration

Prevail and Lonza Deepen Partnership with New Collaboration

Source: 
BioSpace
snippet: 

Prevail Therapeutics and Switzerland-based Lonza entered into a strategic collaboration focused on the development of the baculovirus/Sf9 expression system for Prevail's pipeline of gene therapy programs aimed at neurodegenerative diseases.